COPD, Chronic Obstructive Pulmonary Disease Clinical Trials

51 recruitingLast updated: June 18, 2026

There are 51 actively recruiting copd, chronic obstructive pulmonary disease clinical trials across 45 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4. Top locations include Beijing, Beijing Municipality, China, London, United Kingdom, Durham, North Carolina, United States. Updated daily from ClinicalTrials.gov.


COPD, Chronic Obstructive Pulmonary Disease Trials at a Glance

51 actively recruiting trials for copd, chronic obstructive pulmonary disease are listed on ClinicalTrialsFinder across 6 cities in 45 countries. The largest study group is Not Applicable with 26 trials, with the heaviest enrollment activity in Beijing, London, and Durham. Lead sponsors running copd, chronic obstructive pulmonary disease studies include AstraZeneca, Imperial College London, and Bastiaan Driehuys.

Browse copd, chronic obstructive pulmonary disease trials by phase

Treatments under study

About COPD, Chronic Obstructive Pulmonary Disease Clinical Trials

Looking for clinical trials for COPD, Chronic Obstructive Pulmonary Disease? There are currently 51 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new COPD, Chronic Obstructive Pulmonary Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about COPD, Chronic Obstructive Pulmonary Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 51 trials

Recruiting

Study That Will Evaluate the Brazilian Population With COPD.

COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca693 enrolled10 locationsNCT06780046
Recruiting
Phase 2

A Study to Assess the Safety, Tolerability, PK and PD of WIN378 in Participants With Moderate - Severe COPD

COPD, Chronic Obstructive Pulmonary Disease
Windward Bio105 enrolled3 locationsNCT07646587
Recruiting
Phase 3

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD

COPD, Chronic Obstructive Pulmonary Disease
Haisco Pharmaceutical Group Co., Ltd.376 enrolled1 locationNCT07583849
Recruiting

COPD Exacerbation Follow Up

COPD, Chronic Obstructive Pulmonary Disease
Viz.ai, Inc.485 enrolled4 locationsNCT07118306
Recruiting
Not Applicable

Isoinertial Training in Patients With COPD

COPD, Chronic Obstructive Pulmonary Disease
Universidad Manuela Beltrán30 enrolled2 locationsNCT07605117
Recruiting

Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment Response

Asthma (Diagnosis)COPD, Chronic Obstructive Pulmonary Disease
Korea University Guro Hospital200 enrolled1 locationNCT07602192
Recruiting
Phase 3

Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination

PneumoniaCOPD, Chronic Obstructive Pulmonary Diseaseacute coronary syndromes (ACS)
University of Brawijaya60 enrolled1 locationNCT07604103
Recruiting
Phase 3

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled920 locationsNCT06283966
Recruiting
Phase 2

Psilocybin Therapy for Psychological Distress in Palliative Patients

COPD, Chronic Obstructive Pulmonary DiseaseMajor Depressive Disorder (MDD)ALS (Amyotrophic Lateral Sclerosis)+2 more
University Medical Center Groningen108 enrolled4 locationsNCT06782724
Recruiting
Not Applicable

Enhanced COPD Management in Suspected Lung Cancer Patients

Lung CarcinomaLung Cancer (Diagnosis)Pulmonary Cancer+8 more
Ditte Krag-Hansen280 enrolled1 locationNCT07543601
Recruiting

Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients

COPD, Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutica Ltda.396 enrolled1 locationNCT07406048
Recruiting

Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets

COPD, Chronic Obstructive Pulmonary DiseaseExacerbation of COPDRhinovirus Infection
Imperial College London50 enrolled1 locationNCT07112235
Recruiting
Not Applicable

Emotional-distress-based Integrated Care Programme in Patients With Stable COPD

COPDCOPD, Chronic Obstructive Pulmonary Disease
University of Zurich15 enrolled1 locationNCT07524023
Recruiting
Phase 2

Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD

COPD, Chronic Obstructive Pulmonary Disease
University of Alberta20 enrolled1 locationNCT06969573
Recruiting

University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2

Smoking, CigaretteCOPD, Chronic Obstructive Pulmonary DiseaseCancer Lung Screening
University of Michigan200 enrolled1 locationNCT07482475
Recruiting
Not Applicable

OMEGA - Dietary Intervention - COPD Trial

COPD, Chronic Obstructive Pulmonary Disease
Johns Hopkins University200 enrolled1 locationNCT05297279
Recruiting
Not Applicable

Probiotics in Pulmonaty Rehabilitation for COPD

COPD, Chronic Obstructive Pulmonary DiseaseBody Composition MeasurementProbiotic Intervention
Fu Jen Catholic University60 enrolled1 locationNCT06717659
Recruiting
Not Applicable

Medical Device Clinical Trial Without CE Marking to Evidence Safety and Performance of the INBENTUS VERSATILE Ventilator in Patients Requiring Assisted/Controlled Mechanical Ventilation and Weaning.

Acute Respiratory Distress Syndrome (ARDS)PneumoniaCOPD, Chronic Obstructive Pulmonary Disease+4 more
Iconic Solutions By Murcia SL81 enrolled1 locationNCT07432191
Recruiting
Not Applicable

Respiratory Rehabilitation and Sleep Quality in COPD Patients

COPD, Chronic Obstructive Pulmonary Disease
University Hospital, Rouen90 enrolled4 locationsNCT06677268
Recruiting

How Nocturnal Hypoventilation Predicts Long-term Response to Non-invasive Ventilation in Hypercapnic COPD Patients

COPDCOPD, Chronic Obstructive Pulmonary DiseaseHypercapnia+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna25 enrolled1 locationNCT07414108